Microarray Core B
微阵列核心B
基本信息
- 批准号:7283910
- 负责人:
- 金额:$ 8.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-06-01 至 2012-05-31
- 项目状态:已结题
- 来源:
- 关键词:Academic Medical CentersBioinformaticsCancer CenterCandidate Disease GeneCollectionComplementary DNACore FacilityDNADNA analysisDataData QualityData SetDiabetes MellitusDiagnosisDigestive System DisordersDiseaseEnsureEquipmentExperimental DesignsGene ExpressionGene Expression ProfilingGene TargetingGenesGenetic PolymorphismGenomeGenome MappingsGenomicsGenotypeGoalsHumanIndividualInformaticsInvestigationInvestmentsKnowledgeLaboratoriesManuscriptsMapsMessenger RNAMethodologyMicroRNAsMicroarray Shared ResourceMolecular ProfilingMusOligonucleotide MicroarraysPolymerase Chain ReactionProcessPublishingRNA InterferenceResearchResearch PersonnelResearch TrainingResourcesReverse Transcriptase Polymerase Chain ReactionSamplingServicesSpottingsSupport SystemTechniquesTechnologyTimeTranslatingVariantbasecostdensitydesignexpression vectorfollow-upfunctional genomicsgene functionimprovedinterestmammalian genomepreventprogramsresearch studystructural genomicstoolweb interface
项目摘要
The large-scale analysis of gene expression profiles was the first hallmark in the transition from structural
genomics to functional genomics. Genomic-scale expression profiling experiments require large technical
and computational investments to facilitate both experimentation and the analysis of the large data sets
produced. These investments are beyond the capabilities of most laboratories or small groups. To provide
access to these important technologies, the DMA Microarray Core, operating within the Vanderbilt Microarray
Shared Resource (VMSR) has been established with major support from the VDDRC, the Diabetes
Research and Training Center, the Vanderbilt-lngram Cancer Center (VICC), and the Vanderbilt University
Medical Center Office of Research. The objectives of this core are to assist investigators in performing
genomic investigations using high-throughput and cutting-edge technologies that are financially or technically
prohibitive to utilize in individual labs. The services in the core have been substantially increased since the
last application. While previous services were limited to cDNA-based arrays produced in the core for mouse
and human, current services include a variety of commercial array platforms in addition to comprehensive
oligonucleotide arrays for mouse and human. Supported commercial arrays include Affymetrix, Applied
Biosystems, and CodeLink. In addition to gene expression profiling services, the core offers high-throughput
genotyping services using the Affymetrix mapping arrays and Targeted Genotyping (ParAllele) platforms.
Verification of microarray results (expression and genotyping) by real-time PCR is also available. The
newest services established in the core are profiling of microRNAs and the manipulation of gene expression
via RNAi and cDNA over-expression to support functional screens. The core continues to maintain a
comprehensive informatics program with two full-time analysts available. Significantly, the core has
developed an on-line project management system that supports all sample submission, project annotation,
and data access through an efficient web interface. Since 2002, the core has published several
manuscripts, processed hundreds of samples for VDDRC investigators, and continued to expand and refine
services to meet the research needs of the Vanderbilt DDRC.
The Core provides investigators with cutting edge access to human genomic technologies in order to
prevent, diagnose or improve treatment of digestive diseases and disorders.
基因表达谱的大规模分析是从结构的过渡的第一个标志
功能基因组学的基因组学。基因组尺度表达分析实验需要大量技术
和计算投资,以促进实验和分析大数据集
生产。这些投资超出了大多数实验室或小组的能力。提供
访问这些重要技术,即DMA微阵列核心,在范德比尔特微阵列中运行
共享资源(VMSR)是在VDDRC(糖尿病)的主要支持下建立的
研究与培训中心,Vanderbilt-Lngram癌症中心(VICC)和范德比尔特大学
医疗中心研究办公室。该核心的目标是协助调查人员执行
使用高通量和尖端技术在财务上或技术上都是基因组研究
在单个实验室中使用的过敏性。自从
最后一个应用。虽然先前的服务仅限于鼠标核心产生的基于cDNA的阵列
当前的服务包括各种商业阵列平台,除了全面
小鼠和人类的寡核苷酸阵列。支持的商业阵列包括Affymetrix,应用
生物系统和Codelink。除了基因表达分析服务外,核心还提供高通量
使用Affymetrix映射阵列和靶向基因分型(Parallele)平台的基因分型服务。
还提供了实时PCR的微阵列结果(表达和基因分型)的验证。这
核心建立的最新服务是microRNA的分析和基因表达的操纵
通过RNAi和cDNA过表达来支持功能屏幕。核心继续保持
综合信息计划,可提供两位全职分析师。重要的是,核心具有
开发了一个在线项目管理系统,该系统支持所有样本提交,项目注释,
以及通过有效的Web界面访问数据。自2002年以来,核心已经发布了几篇
手稿,为VDDRC调查人员处理了数百个样本,并继续扩展和完善
满足Vanderbilt DDRC的研究需求的服务。
核心为研究人员提供了对人类基因组技术的最先进的机会
预防,诊断或改善对消化系统疾病和疾病的治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shawn Edward Levy其他文献
Shawn Edward Levy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shawn Edward Levy', 18)}}的其他基金
Characterizing pediatric genomes through an optimized sequencing approach
通过优化的测序方法表征儿科基因组
- 批准号:
10017693 - 财政年份:2016
- 资助金额:
$ 8.34万 - 项目类别:
Characterizing pediatric genomes through an optimized sequencing approach
通过优化的测序方法表征儿科基因组
- 批准号:
10260464 - 财政年份:2016
- 资助金额:
$ 8.34万 - 项目类别:
Characterizing pediatric genomes through an optimized sequencing approach
通过优化的测序方法表征儿科基因组
- 批准号:
9356558 - 财政年份:2016
- 资助金额:
$ 8.34万 - 项目类别:
Characterizing pediatric genomes through an optimized sequencing approach
通过优化的测序方法表征儿科基因组
- 批准号:
9252143 - 财政年份:2016
- 资助金额:
$ 8.34万 - 项目类别:
Characterizing pediatric genomes through an optimized sequencing approach
通过优化的测序方法表征儿科基因组
- 批准号:
9815793 - 财政年份:2016
- 资助金额:
$ 8.34万 - 项目类别:
Characterizing pediatric genomes through an optimized sequencing approach
通过优化的测序方法表征儿科基因组
- 批准号:
9565172 - 财政年份:2016
- 资助金额:
$ 8.34万 - 项目类别:
相似国自然基金
2023年(第四届)国际生物数学与医学应用研讨会
- 批准号:12342004
- 批准年份:2023
- 资助金额:8.00 万元
- 项目类别:专项项目
突变和修饰重塑蛋白质亚细胞定位的生物信息学研究
- 批准号:32370698
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于生物信息学的类风湿性关节炎患者衰弱预测模型的构建与验证
- 批准号:82301786
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于结构表征的蛋白质与长链非编码RNA相互作用预测的生物信息学方法研究
- 批准号:62373216
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
蛋白质降解决定因子的生物信息学筛选及其耐药突变的多组学分析研究
- 批准号:32300528
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigating High-Risk Epigenetic Modifying Alterations on JAK2VF Dependency and Fibrotic Progression in Myeloproliferative Neoplasms (MPNs)
研究骨髓增生性肿瘤 (MPN) 中 JAK2VF 依赖性和纤维化进展的高风险表观遗传修饰改变
- 批准号:
10723901 - 财政年份:2023
- 资助金额:
$ 8.34万 - 项目类别:
Integrating imaging and biopsy-derived molecular markers for the pre-surgical detection of indolent and aggressive early stage lung adenocarcinoma
整合成像和活检衍生的分子标记物,用于惰性和侵袭性早期肺腺癌的术前检测
- 批准号:
10737330 - 财政年份:2023
- 资助金额:
$ 8.34万 - 项目类别:
Boston Area Diabetes and Endocrinology Research Center (BADERC)
波士顿地区糖尿病和内分泌研究中心 (BADERC)
- 批准号:
10586200 - 财政年份:2023
- 资助金额:
$ 8.34万 - 项目类别:
Isabl GxT: A clinically actionable whole genome and transcriptome precision medicine platform
Isabl GxT:临床上可操作的全基因组和转录组精准医学平台
- 批准号:
10697472 - 财政年份:2023
- 资助金额:
$ 8.34万 - 项目类别: